Ginza Phoenix Clinic: NK Cell Immunotherapy and Stem Cell Regeneration
Medical Supporter — Information Notice
This article is a summary of international medical information and is not medical advice; it cannot replace the diagnosis or treatment plan of your attending physician. The medical technologies, drug information and clinical data presented here are compiled from public literature and official statements of Japanese medical institutions; the applicability and outcome of any therapy vary with each patient and must be assessed individually by a qualified physician.
Ginza Phoenix Clinic, located in Tokyo's Ginza district, integrates dual expertise: advanced cancer immunotherapy and regenerative stem cell medicine. Led by physicians with extensive regenerative medicine research backgrounds, the clinic explores therapeutic possibilities beyond standard cancer protocols.
Primary Treatment Domains
High-Activity NK Cell Immunotherapy: NK cells (natural killer cells) function as first-line immune defense.
- Tumor recognition (research data): Published studies report that NK cells can recognize cancer cells with low MHC class I expression, which may escape T cell surveillance (for reference only; not established in Japan)
- Relationship with antibody drugs: Published studies report that NK cells take part in the antibody-dependent cellular cytotoxicity (ADCC) of antibody drugs such as trastuzumab and rituximab
- Culture period: The clinic uses its own culture method, with a culture period of about three weeks
Mesenchymal Stem Cell (MSC) Therapy: Addresses tissue regeneration and repair needs with regulatory-compliant stem cell protocols.
- Differentiation and proliferation (under research): Researchers are exploring whether the self-renewal capacity of stem cells can help repair tissue damaged by cancer treatment or aging (effects not established in Japan)
- Quality control: Cells are cultured at the clinic's in-house cell culture facility under the clinic's quality-control procedures
Regulatory Filing and Facilities
Ginza Phoenix Clinic has submitted Class II and Class III plans for the provision of regenerative medicine to Japan's Ministry of Health, Labour and Welfare. Cell processing is carried out at the clinic's in-house facility.
Data Source
Ginza Phoenix Clinic Regenerative Medicine Program
Medical Supporter was formerly certified as an international medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).
Considering medical care in Japan? Need information and support?
We help you organize the information needed for medical travel to Japan, liaise with Japanese medical institutions, and arrange a second-opinion consultation.The first consultation is free (initial direction only; further services are quoted separately); an advisor will help you clarify the next steps.